Search

everythinglearnresearchcommunity

for

Search:↓

Shampoos have evolved into multifunctional products with patented innovations for different hair needs and can include medicinal herbs for hair and scalp health.

The document reviews patents on nanoparticle systems used to deliver drugs, discussing their creation, use in treatments, and commercial applications.

Patents don't guarantee money; inventors must work hard and stay involved.

Minoxidil treats hair loss, promotes growth, has side effects, and has recent patents.

Women inventors focus more on women's health, but there are few of them.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Jasmonic acid and its derivatives play important roles in plant health and have potential uses in medicine and agriculture.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

The document shows the state of pharmaceutical patents as of 1999, focusing on treatments for various diseases.

The document reviews 20 U.S. patents from July and August 2004 about new drug forms, cancer treatments, aroma chemicals, statin drugs, and various chemical production methods.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

New patents include innovations in skin and hair care, disease treatment, plant stress tolerance, and protein purification.

The article concludes that recent legal rulings have strengthened the protection of pharmaceutical patents against generic competition.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

European patent law now allows patents for new uses and dosages of known drugs, but protection scope is unclear.

UK courts and the European Patent Office are now more open to granting patents for new dosage regimes.

The document suggests creating a secure database for indigenous knowledge and recommends that the TKDL actively fight patents that slightly alter traditional knowledge.

The document updates on EU legal changes, including pharmaceutical patents, class actions in Italy, and various drug-related rulings.

The UK Court of Appeal ruled that new dosing regimens for drugs can be patented, aligning with the European Patent Office's approach.

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.

Boosting mitochondrial energy production with supplements like acetyl-L-carnitine may improve aging-related cellular function and health conditions.

3D skin bioprinting, using skin bioinks like collagen and gelatin, is growing fast and could help treat wounds, burns, and skin cancers, as well as test cosmetics and drugs.

Low-level laser therapy is effective and safe for treating hair loss.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

The document suggests reevaluating the patent system to ensure public benefits from pharmaceutical privileges and to encourage more significant innovations.

Coffee and its by-products are promising for skin health benefits in cosmetics and help reduce environmental impact.